PRO Therapeutics

PRO Therapeutics is a dynamic and innovative biotechnology research company dedicated to pioneering advancements in regenerative medicine. Based in Manchester, NH, at 500 N. Commercial Street, Suite 206, PRO Therapeutics is committed to developing transformative solutions for soft-tissue repair. Born from groundbreaking research at the University of Michigan and partnered with the Advanced Regenerative Manufacturing Institute (ARMI), the company is focused on creating regenerative products that address significant unmet needs in the medical field.

PRO Therapeutics’ initial focus is on developing a revolutionary regenerative graft for rotator cuff repair, reflecting the company’s commitment to precision and efficacy. Through meticulous research and strategic collaborations, PRO Therapeutics aims to establish itself as a leader in the regenerative medicine space, constantly pushing the boundaries of what’s possible. The company's dedication to scientific rigor and patient-centric innovation ensures that PRO Therapeutics remains at the forefront of its industry, poised for substantial growth and lasting impact.

With a team of dedicated professionals, including Amanda Stagmer, Lisa Larkin, Christopher Kennedy, and Julie Lenzer, PRO Therapeutics is driven by a shared vision of improving patient outcomes and advancing the field of regenerative medicine. The company’s headquarters in Manchester, NH, serves as a hub for its groundbreaking research and development efforts. Management is currently focused on completing details regarding long-term strategic goals, which will be released soon. We invite our manager to create a customized and exclusive company showcase and product listing on our platform to further highlight PRO Therapeutics’ capabilities.